Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Epoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating epoprostenol in addition to conventional therapy for frostbite injury; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epoprostenol (Epoprostenol)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Frostbite | Phase 4 | Status: NOT_YET_RECRUITING